# US 2026/0232914 A1 · Drug delivery device with indicator

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0232914 A1
- Document ID: US20260232914A1
- Status: Published application
- Kind: A1
- Application number: 19/312,833
- Filed: 2025-08-28
- Published: 2026-08-13
- Earliest claimed: 2016-08-14
- Assignees: Insulet Corporation
- Applicants: Insulet Corporation
- Inventors: David NAZZARO; Ian MCLAUGHLIN; Daniel ALLIS; Simon KOZIN; Maureen MCCAFFREY
- Web page: https://patentgrep.com/patent/US20260232914A1

## CPC

- A61M 5/16886: {for measuring fluid flow rate, i.e. flowmeters}
- A61M 5/31568: {Means keeping track of the total dose administered, e.g. since the cartridge was inserted}
- A61M 5/14248: {of the skin patch type}
- A61M 5/1452: {pressurised by means of pistons}
- A61M 5/1454: {spring-actuated, e.g. by a clockwork}
- A61M 5/1684: {by detecting the amount of infusate remaining, e.g. signalling end of infusion}
- A61M 5/2033: {Spring-loaded one-shot injectors with or without automatic needle insertion (multishot dosing syringes A61M5/31525, needle insertion only A61M5/3287)}
- G01F 13/00: Apparatus for measuring by volume and delivering fluids or fluent solid materials, not provided for in the preceding groups
- A61M 5/1685: {by detection of position of a floating member}
- A61M 5/3129: {Syringe barrels (A61M5/3205, A61M5/50 take precedence)}
- A61M 5/3155: {by rotational movement of dose setting member, e.g. during setting or filling of a syringe}
- A61M 2005/14252: {with needle insertion means}
- A61M 2005/14533: {cam actuated}
- A61M 2005/2073: {preventing premature release, e.g. by making use of a safety lock}
- A61M 2005/31518: {designed to reduce the overall size of an injection device, e.g. using flexible or pivotally connected chain-like rod members}
- A61M 2202/0468: non-physiological
- A61M 2205/3306: Optical measuring means
- A61M 2205/3317: Electromagnetic, inductive or dielectric measuring means
- A61M 2205/3379: Masses, volumes, levels of fluids in reservoirs, flow rates
- A61M 2205/3389: Continuous level detection (A61M2205/3393 takes precedence)
- A61M 2205/581: by audible feedback
- A61M 2205/582: by tactile feedback
- A61M 2205/583: by visual feedback
- A61M 2205/584: having a color code
- G01F 11/029: {provided with electric controlling means (G01F11/022 and G01F11/024 take precedence)}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G01F: MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME

## Abstract

Systems and methods for monitoring an operational state and/or a fill status of a drug container of a drug delivery device are provided. The drug container can hold a liquid drug. A plunger can be positioned within the drug container. A drive system can advance the plunger to expel the liquid drug from the container. A monitoring system can detect a movement and/or a position of the plunger and/or any component coupled to the plunger. The detection can enable determination of an amount of liquid drug that has been expelled and/or an amount of liquid drug remaining in the drug container. Dosing rates, flow rates, and dosage completion can also be determined.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A wearable drug delivery apparatus, comprising:
a drug container configured to hold a liquid drug;
a plunger including a plunger wiper comprising a conductive element, wherein the plunger is positioned within the drug container and operable to move within the drug container;
a monitoring system coupled to the drug container; and
a controller electrically coupled to the monitoring system,
wherein the monitoring system includes:
a first conductive pin coupled to a first conductive trace;
a second conductive pin, wherein:
the first conductive pin and the second conductive pin are coupled to the controller,
the first conductive pin is further coupled to a first end of a second conductive trace,
the second conductive pin is coupled to a second end of the second conductive trace, and
the plunger wiper is operable to electrically contact the first conductive trace and the second conductive trace as the plunger moves within the drug container.

### Claim 22 (depends on 21)

The wearable drug delivery apparatus of claim 21, wherein the plunger is configured to expel the liquid drug through a fluid path.

### Claim 23 (depends on 21)

The wearable drug delivery apparatus of claim 21, wherein the controller is operable to:
determine a resistance value between the first conductive pin and the second conductive pin as the plunger wiper moves along the first conductive trace and the second conductive trace.

### Claim 24 (depends on 21)

The wearable drug delivery apparatus of claim 21, wherein the first conductive trace extends along a longitudinal length of the drug container.

### Claim 25 (depends on 21)

The wearable drug delivery apparatus of claim 21, wherein the plunger wiper is operable to substantially short circuit the second conductive trace by contacting the first conductive trace when the drug container is filled with the liquid drug.

### Claim 26 (depends on 21)

The wearable drug delivery apparatus of claim 21, wherein the second conductive trace extends along a longitudinal length of the drug container and has a sawtooth configuration.

### Claim 27 (depends on 21)

The wearable drug delivery apparatus of claim 21, wherein the second conductive trace has a linearly increasing resistance.

### Claim 28 (depends on 21)

The wearable drug delivery apparatus of claim 21, wherein the monitoring system further comprises:
a third conductive pin coupled to an end of the second conductive trace that is approximately at an initial position of the plunger.

### Claim 29 (depends on 21)

The wearable drug delivery apparatus of claim 21, wherein:
the plunger wiper is operable to:
maintain a circuit between the first conductive trace and the second conductive trace as the plunger moves to different locations within the drug container; and
the controller is operable to:
detect different resistance values between the first conductive pin and the second conductive pin as the plunger wiper moves with the plunger to the different locations within the drug container.

### Claim 30 (depends on 21)

The wearable drug delivery apparatus of claim 21, wherein the first conductive trace and the second conductive trace are formed in a substantially linear configuration.

### Claim 31

A monitoring system of a drug delivery device, comprising:
a first conductive pin coupled to a first conductive trace and to a first end of a second conductive trace; and
a second conductive pin coupled to a second end of the second conductive trace, wherein a plunger wiper of a plunger is operable to electrically contact the first conductive trace and the second conductive trace as the plunger moves within a drug container.

### Claim 32 (depends on 31)

The monitoring system of claim 31, further comprising a controller electrically coupled to both the first conductive pin and the second conductive pin, wherein the controller is configured to determine a position of the plunger based on resistance values between the first conductive pin and the second conductive pin as the plunger wiper moves along the first conductive trace and the second conductive trace.

### Claim 33 (depends on 32)

The monitoring system of claim 32, wherein the controller is configured to determine a fill status of the drug container based on the resistance values.

### Claim 34 (depends on 31)

The monitoring system of claim 31, wherein a portion of the first conductive pin and a portion of the second conductive pin extends into the drug container.

### Claim 35 (depends on 34)

The monitoring system of claim 34, wherein the portions of the first conductive pin and the second conductive pin contact a liquid drug contained within the drug container.

### Claim 36 (depends on 31)

The monitoring system of claim 31, wherein the first conductive trace and the second conductive trace extend along a longitudinal length of the drug container.

### Claim 37 (depends on 31)

The monitoring system of claim 31, wherein the second conductive trace has a linearly increasing resistance.

### Claim 38 (depends on 31)

The monitoring system of claim 31, wherein the monitoring system further comprises:
a third conductive pin coupled to an end of the second conductive trace that is approximately at an initial position of the plunger.

### Claim 39 (depends on 38)

The monitoring system of claim 38, wherein the third conductive pin is coupled to a third conductive trace.

### Claim 40 (depends on 39)

The monitoring system of claim 39, wherein the controller is electrically coupled to the third conductive pin and is configured to determine a position of the plunger based on resistance values between the third conductive pin and one or more of the first conductive pin and the second conductive pin.
